Isarna Therapeutics

About:

Isarna Therapeutics is a biotechnology company.

Website: http://www.isarna-therapeutics.com

Top Investors: MIG Capital, Global Asset Capital, Global Asset Fund, AT Impf, S-Refit

Description:

Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.